Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT05667805

Coagulation in Cirrhosis

Led by Medical University of Vienna · Updated on 2025-01-14

400

Participants Needed

1

Research Sites

214 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Out of fear of bleeding, liver cirrhosis patients are often treated prophylactically with blood and coagulation products before minor interventions. The COUCH study will examine whether these patients benefit from a restrictive administration of coagulation products.

CONDITIONS

Official Title

Coagulation in Cirrhosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients at the University Hospital of Vienna with diagnosed liver cirrhosis and abnormal coagulation parameters (INR >1.5 and/or platelet count <50 G/L)
  • Scheduled for elective invasive liver interventions including biopsy or puncture, microwave ablation (MWA) or radiofrequency ablation (RFA), transjugular intrahepatic portosystemic shunt (TIPS), or percutaneous transhepatic cholangiography drain (PTCD)
  • Adults aged 18 years or older
Not Eligible

You will not qualify if you...

  • Missing informed consent or inability to consent
  • Age younger than 18 years
  • Pregnancy or breastfeeding
  • Presence of manifest ascites
  • Chronic kidney injury stage G4 or G5 according to KDIGO
  • Uninterrupted anticoagulant therapy, except acetylsalicylic acid (ASA)
  • History of bleeding or clinical signs of hemorrhagic diathesis such as petechia, ecchymosis, mucosal bleeding, family history of bleeding disorders, menorrhagia, or prolonged bleeding after surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

General Hospital of the Medical University of Vienna

Vienna, Austria, 1090

Actively Recruiting

Loading map...

Research Team

A

Armin Langauer, MD

CONTACT

K

Kristina Nieding, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Coagulation in Cirrhosis | DecenTrialz